RECBIO-B: Form of Proxy for use at the 2023 Annual General Meeting to be held on Wednesday, May 8, 2024
RECBIO-B: NOTICE OF 2023 ANNUAL GENERAL MEETING
RECBIO-B: CIRCULAR OF 2023 ANNUAL GENERAL MEETING
RECBIO-B: 2023 Annual Report
RECBIO-B: 2023 Environmental, Social and Governance Report
RECBIO-B: PROPOSED ELECTION OF DIRECTORS OF THE SECOND SESSION OF THE BOARD AND PROPOSED ELECTION OF NON-EMPLOYEE REPRESENTATIVE SUPERVISORS OF THE SECOND SESSION OF THE SUPERVISORY BOARD
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
RECBIO-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND NO FURTHER EXTENSION OF VALIDITY PERIOD OF RESOLUTIONS ON ISSUANCE OF DOMESTIC SHARES FOR 2023
RECBIO-B: DATE OF BOARD MEETING
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
RECBIO-B: Letter to Non-registered Shareholder - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
RECBIO-B: Letter to Registered Shareholder - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
RECBIO-B: VOLUNTARY ANNOUNCEMENT POSITIVE RESULTS IN THE INTERIM ANALYSIS OF THE CLINICAL TRIAL OF THE COMPANY''S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 IN THE PHILIPPINES
RECBIO-B: ANNOUNCEMENT IN RELATION TO EXTENSION OF VALIDITY PERIOD OF RESOLUTIONS ON ISSUANCE OF DOMESTIC SHARES
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
RECBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
RECBIO-B: 2023 Interim Report
No Data